PAPER Husain-Ponnampalam R, Turnbull V, Tarlac V, Storey E
SEARCH RESULTS
331254 RESULTS
PAPER Ghosh AS, Wang B, Pozniak CD, Chen M, Watts RJ, Lewcock JW
DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity.
J Cell Biol. 2011 Sep 5;194(5):751-64. PubMed: 21893599PAPER Zeng KW, Zhang T, Fu H, Liu GX, Wang XM
Modified Wu-Zi-Yan-Zong prescription, a traditional Chinese polyherbal formula, suppresses lipopolysaccharide-induced neuroinflammatory processes in rat astrocytes via NF-κB and JNK/p38 MAPK signaling pathways.
Phytomedicine. 2012 Jan 15;19(2):122-9. PubMed: 21893401PAPER Karasinska JM, Hayden MR
Cholesterol metabolism in Huntington disease.
Nat Rev Neurol. 2011;7(10):561-72. PubMed: 21894212PAPER Westermark P, Andersson A, Westermark GT
Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Physiol Rev. 2011 Jul;91(3):795-826. PubMed: 21742788PAPER Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, Lee JH
Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
BMC Med Genet. 2011;12:104. PubMed: 21812969PAPER Frydman-Marom A, Convertino M, Pellarin R, Lampel A, Shaltiel-Karyo R, Segal D, Caflisch A, Shalev DE, Gazit E
Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue.
ACS Chem Biol. 2011 Nov 18;6(11):1265-76. PubMed: 21892833PAPER Li S, Itoh M, Ohta K, Ueda M, Mizuno A, Ohta E, Hida Y, Wang MX, Takeuchi K, Nakagawa T
The expression and localization of Prune2 mRNA in the central nervous system.
Neurosci Lett. 2011 Oct 10;503(3):208-14. PubMed: 21893162PAPER Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-Maclachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD
Association of apolipoprotein E allele {varepsilon}4 with late-onset familial and sporadic Alzheimer's disease.
Neurology. 2011 Sep 6;77(10):950. PubMed: 21893669PAPER Costa AC
On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome.
Dev Neurosci. 2011;33(5):414-27. PubMed: 21893967PAPER Hashimoto M, Tozawa R, Katakura M, Shahdat H, Haque AM, Tanabe Y, Gamoh S, Shido O
Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats.
Food Funct. 2011 Jul;2(7):386-94. PubMed: 21894325PAPER Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE,
Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Arch Gen Psychiatry. 2011 Sep;68(9):961-9. PubMed: 21893661PAPER Monti MC, Margarucci L, Tosco A, Riccio R, Casapullo A
New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component.
Food Funct. 2011 Jul;2(7):423-8. PubMed: 21894330Abhijit Dam on Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
COMMENT Excellent paper. 0 ratuldam
Gerard Roberts on Resolving Controversies on the Path to AD Therapeutics
COMMENT Dennis Selkoe's Perspective is illuminating. The glass is half full. gerryroberts2 0
Current Filters
No filters selected